Gongwin Biopharm Co., Ltd. announced a private placement of 30,000,000 shares at issue price of TWB 10 per share for gross proceeds of TWB 300 million on May 8, 2024. The transaction includes participation from returning investor, Gongwin Biopharm Holdings Co., Ltd to retain its 100% stake in the company. The transaction has been approved at the board of directors of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
186 TWD | -1.33% | -0.80% | +0.81% |
1st Jan change | Capi. | |
---|---|---|
+0.81% | 655M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.27% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 6617 Stock
- News Gongwin Biopharm Holdings Co., Ltd.
- Gongwin Biopharm Co., Ltd. announced that it expects to receive TWD 300 million in funding from Gongwin Biopharm Holdings Co., Ltd.